Get the Stockscreener App
9.16
1.89%
0.17
Cel-Sci Corp. stock is traded at $9.16, with a volume of 40,253.
It is up +1.89% in the last 24 hours and up +2.00% over the past month.
CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company's Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.
See More
Previous Close:
$8.99
Open:
$9.2
24h Volume:
40,253
Relative Volume:
0.15
Market Cap:
$63.04M
Revenue:
-
Net Income/Loss:
$-26.92M
P/E Ratio:
-17.96
EPS:
-0.51
Net Cash Flow:
$-18.92M
1W Performance:
+3.50%
1M Performance:
+2.00%
6M Performance:
+2.98%
1Y Performance:
-66.25%
1-Day Range:
$8.8079
$9.20
1-Week Range:
$8.50
$9.3524
52-Week Range:
$1.98
$32.70
Cel-Sci Corp. Stock (CVM) Company Profile
Name
Cel-Sci Corp.
Sector
Industry
Phone
703-506-9460
Address
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
9.16 | 71.86M | 0 | -26.92M | -18.92M | -0.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Initiated | H.C. Wainwright | Buy |
| Mar-02-15 | Initiated | Dawson James | Buy |
Cel-Sci Corp. Stock (CVM) Latest News
How CEL SCI Corporation (LSR) stock responds to job market shiftsTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com
Can Cel Sci Corporation stock test all time highsProfit Target & Verified Swing Trading Watchlists - newser.com
Using data filters to optimize entry into CEL SCI CorporationWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
What risks investors should watch in CEL SCI Corporation stockIPO Watch & Reliable Entry Point Alerts - newser.com
Why CEL SCI Corporation stock is trending among retail traders2025 Retail Activity & Stepwise Trade Signal Implementation - newser.com
Will CEL SCI Corporation (LSR) stock split increase liquidity2025 Macro Impact & Fast Entry Momentum Alerts - newser.com
What recovery options are there for CEL SCI Corporation2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
Will CEL SCI Corporation (LSR) stock deliver compounding returnsQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com
What insider purchases suggest about Cel Sci Corporation stockJuly 2025 Outlook & Consistent Profit Alerts - newser.com
Why CEL SCI Corporation (LSR) stock appeals to dividend investorsJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
How Have Insiders Been Trading Cel-Sci Corp (CVM) Stock? - fostersleader.com
CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 - Investing News Network
Market Moves: How buyback programs support Cel Sci Corporation stockQuarterly Trade Review & AI Forecast Swing Trade Picks - nchmf.gov.vn
20-Minute Presentation: CEL-SCI Unveils Multikine Roadmap at LD Micro Oct 21 Virtual Event - Stock Titan
Will Cel Sci Corporation stock gain from green policiesPrice Action & Stepwise Entry and Exit Trade Signals - newser.com
Is CEL SCI Corporation building a consolidation baseQuarterly Growth Report & Fast Gain Swing Alerts - newser.com
Highs Report: Why CEL SCI Corporation (LSR) stock fits value portfoliosQuarterly Earnings Report & Verified Swing Trading Watchlists - nchmf.gov.vn
How buyback programs support CEL SCI Corporation (LSR) stock2025 Risk Factors & Stepwise Trade Signal Guides - nchmf.gov.vn
Fluence Energy Stock Rises 15% Pre-Market On Solar-Storage Project Announcement - Stocktwits
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine - Menafn.com
Cyngn Stock Eyes Third Day Of Gains: What's Driving The Buzz? - Stocktwits
What makes CEL SCI Corporation (LSR) stock appealing to growth investorsJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Oct 21 9:30 a.m. PST: CEL‑SCI to Present Multikine Roadmap at LD Micro Main Event - Stock Titan
Will CEL SCI Corporation stock pay special dividendsGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Will CEL SCI Corporation price bounce be sustainableChart Signals & Stepwise Swing Trade Plans - newser.com
CEL SCI Corporation stock volume spike explainedQuarterly Trade Review & Growth Focused Entry Reports - newser.com
Can CEL SCI Corporation (LSR) stock survive global slowdownQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
Why CEL SCI Corporation stock is a value investor pickWeekly Trade Recap & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-03 01:37:57 - newser.com
Is CEL SCI Corporation stock bottoming out2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
CEL SCI Corporation stock momentum explained2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Will Cel Sci Corporation stock announce a stock splitMarket Performance Recap & Growth Focused Stock Pick Reports - newser.com
CEL-SCI (NYSE:CVM) Stock Price Up 8% – Time to Buy? - Defense World
Cel-Sci Stock Slips After Public Offering: Retail's Neutral - MSN
Cel-Sci Corp. Stock (CVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):